These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1016367

  • 1. [Use of steroid and nonsteroid anabolites in ischemic heart disease].
    Leshchinskiĭ LA, Shinkareva IA.
    Klin Med (Mosk); 1976 Apr; 54(4):38-43. PubMed ID: 1016367
    [No Abstract] [Full Text] [Related]

  • 2. [Economic effectiveness of antirecurrence treatment of peptic ulcer].
    Lomazova MM, Kabkalo DN.
    Vrach Delo; 1976 Sep; (9):91-2. PubMed ID: 824821
    [No Abstract] [Full Text] [Related]

  • 3. [Change in the protein and electrolyte metabolism under the effect of anabolic steroids and panangin in patients with myocardial infarct].
    Leshchinskiĭ LA, Trusov VV, Shinkareva IA.
    Klin Med (Mosk); 1978 Jan; 56(1):69-74. PubMed ID: 633803
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction].
    Jiang XR, Chen WP, Shi HL, Zhou LF.
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):36-9. PubMed ID: 6232818
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of butadione on lipid metabolism in chronic ischemic heart disease patients].
    Ermalinskiĭ AF, Balakin AK, Iukhnovets RA, Vedenina RF.
    Vrach Delo; 1986 Feb; (2):53-5. PubMed ID: 3085352
    [No Abstract] [Full Text] [Related]

  • 6. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI.
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract] [Full Text] [Related]

  • 7. [Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
    Smolenskiĭ VS, Abinder AA.
    Sov Med; 1977 Jan; (1):44-8. PubMed ID: 15321
    [No Abstract] [Full Text] [Related]

  • 8. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI.
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract] [Full Text] [Related]

  • 9. [The use of Nerobol in the treatment of patients with rheumatic heart disease and circulatory insufficiency].
    Beĭ PI.
    Klin Med (Mosk); 1968 Jun; 46(6):104-6. PubMed ID: 5710561
    [No Abstract] [Full Text] [Related]

  • 10. [Influence of an anabolic steroid on phenylalaninemia in dystrophic infants].
    Panigada G, Perletti L, Magni L, Giovannini M.
    Minerva Pediatr; 1968 Mar 03; 20(9):491-4. PubMed ID: 5745083
    [No Abstract] [Full Text] [Related]

  • 11. [Certain methods of drug therapy of ischemic heart disease].
    Leshchinskiĭ LA, Shinkareva IA.
    Sov Med; 1975 Apr 03; (4):68-74. PubMed ID: 1188463
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of progressive muscular dystrophy with anabolics and uridine-5-triphosphoric acid].
    Valente VL, Caprarulo CC, Luchetta MR, Nenkies L, Miani J, De Zubizarreta CS.
    Prensa Med Argent; 1966 May 20; 53(20):1130-4. PubMed ID: 5916532
    [No Abstract] [Full Text] [Related]

  • 13. [Use of anabolic hormones for the treatment of cardiovascular patients].
    Zharov EI, Segal' RG.
    Kardiologiia; 1969 Jan 20; 9(1):144-53. PubMed ID: 4896687
    [No Abstract] [Full Text] [Related]

  • 14. [Preventive treatment of ischemic heart disease with obsidan and nerobolil under ambulatory conditions].
    Ianovskiĭ GV, Shevchuk SG, Girina NI, Petrusha GN.
    Vrach Delo; 1978 Jun 20; (6):16-8. PubMed ID: 695461
    [No Abstract] [Full Text] [Related]

  • 15. [Combined therapeutic use of nerobol and potassium salts in ischemic heart disease].
    Leschinskiĭ LA, Kharitonova VV.
    Ter Arkh; 1972 Sep 20; 44(9):40-4. PubMed ID: 4660401
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR.
    Vrach Delo; 1974 Aug 20; 0(8):15-7. PubMed ID: 4153197
    [No Abstract] [Full Text] [Related]

  • 20. [Use of nerobol in combination with potassium salts in patients with chronic coronary insufficiency].
    Leshchinskiĭ LA, Kharitonova VV.
    Klin Med (Mosk); 1970 Oct 20; 48(10):38-42. PubMed ID: 5505243
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.